EHRA Premium Access

Incidence and exploratory analysis of cancer development after new on-set atrial fibrillation

Topic: Prevalence and Incidence of Atrial Fibrillation

Congress Session

About the speaker

Doctor Francisco Javier Quesada Ocete

GENERAL UNIVERSITY HOSPITAL OF VALENCIA CONSORTIUM, Valencia (Spain)
0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Thumbnail

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Thumbnail

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

Thumbnail

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

Thumbnail

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Thumbnail

Access the full session

ePosters Day 2

Speakers: Doctor F. Quesada Ocete, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Smartwatch-based detection of atrial arrhythmia using a deep neural network in a tertiary care hospital

5 April 2022

EHRA Premium Access

Initial experience with a novel pulsed field ablation catheter for ablation of atrial fibrillation: procedural findings and acute safety.

4 April 2022

This platform is supported by

logo Novo Nordisk